Cigna Group $CI Shares Acquired by Invesco Ltd.

Invesco Ltd. boosted its holdings in Cigna Group (NYSE:CI) by 15.9% in the second quarter, HoldingsChannel reports. The firm owned 1,620,938 shares of the health services provider’s stock after purchasing an additional 222,058 shares during the period. Invesco Ltd.’s holdings in Cigna Group were worth $535,850,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of CI. 1832 Asset Management L.P. acquired a new position in shares of Cigna Group in the 2nd quarter valued at approximately $2,516,000. CW Advisors LLC increased its stake in shares of Cigna Group by 64.0% in the second quarter. CW Advisors LLC now owns 34,675 shares of the health services provider’s stock worth $11,463,000 after buying an additional 13,535 shares during the last quarter. Twin Peaks Wealth Advisors LLC bought a new stake in shares of Cigna Group in the second quarter worth $52,000. River Wealth Advisors LLC raised its holdings in Cigna Group by 2.7% in the second quarter. River Wealth Advisors LLC now owns 2,592 shares of the health services provider’s stock valued at $857,000 after acquiring an additional 67 shares in the last quarter. Finally, Groupe la Francaise bought a new position in Cigna Group during the 2nd quarter valued at $5,322,000. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on CI shares. Weiss Ratings reissued a “hold (c)” rating on shares of Cigna Group in a research report on Monday. Zacks Research downgraded Cigna Group from a “hold” rating to a “strong sell” rating in a report on Monday, November 3rd. Wolfe Research dropped their price objective on shares of Cigna Group from $345.00 to $325.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 15th. TD Cowen cut their target price on Cigna Group from $387.00 to $333.00 and set a “buy” rating on the stock in a research note on Tuesday, November 4th. Finally, Guggenheim reaffirmed a “buy” rating and set a $318.00 price target on shares of Cigna Group in a report on Tuesday. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $334.45.

Insider Transactions at Cigna Group

In other news, CEO David Cordani purchased 4,134 shares of Cigna Group stock in a transaction that occurred on Monday, November 3rd. The stock was acquired at an average price of $241.88 per share, for a total transaction of $999,931.92. Following the transaction, the chief executive officer owned 157,935 shares in the company, valued at $38,201,317.80. The trade was a 2.69% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Brian C. Evanko sold 5,368 shares of Cigna Group stock in a transaction that occurred on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the transaction, the insider owned 51,182 shares in the company, valued at approximately $15,354,600. The trade was a 9.49% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.70% of the stock is currently owned by corporate insiders.

Cigna Group Stock Down 0.9%

NYSE CI opened at $267.98 on Friday. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00. The company has a market capitalization of $71.59 billion, a P/E ratio of 11.82, a PEG ratio of 0.98 and a beta of 0.26. The company’s 50 day simple moving average is $283.63 and its 200 day simple moving average is $296.31. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.76 and a quick ratio of 0.76.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.64 by $0.19. The firm had revenue of $69.57 billion for the quarter, compared to analyst estimates of $66.40 billion. Cigna Group had a net margin of 2.29% and a return on equity of 18.80%. The firm’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $7.51 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities research analysts expect that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th will be paid a dividend of $1.51 per share. The ex-dividend date of this dividend is Thursday, December 4th. This represents a $6.04 dividend on an annualized basis and a yield of 2.3%. Cigna Group’s dividend payout ratio is currently 26.64%.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.